SPRAY-CB: A Sham controlled prospective randomized trial of the RejuvenAir system for the treatment of moderate to severe chronic obstructive pulmonary disease with chronic bronchitis

Administered By

Medicine, Pulmonary, Allergy, and Critical Care Medicine

Awarded By

CSA Medical, Inc.

Contributors

Wahidi, Momen Mohammed Principal Investigator

Start/End

April 13, 2020 - July 31, 2024